Search

Your search keyword '"Yoshinobu Ohsaki"' showing total 169 results

Search Constraints

Start Over You searched for: Author "Yoshinobu Ohsaki" Remove constraint Author: "Yoshinobu Ohsaki"
169 results on '"Yoshinobu Ohsaki"'

Search Results

1. Monomerization of ALK Fusion Proteins as a Therapeutic Strategy in ALK-Rearranged Non-small Cell Lung Cancers

2. Acute eosinophilic pneumonia following inhalation of turpentine oil: A case report

3. Highly sensitive detection of ALK resistance mutations in plasma using droplet digital PCR

4. Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: the first report

5. Observation of Zn-photoprotoporphyrin red Autofluorescence in human bronchial cancer using color-fluorescence endoscopy

6. Interstitial lung disease associated with human papillomavirus vaccination

7. Cyclin-dependent kinase 4 upregulation mediates acquired resistance of dabrafenib plus trametinib in BRAF V600E-mutated lung cancer

8. A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy

9. A Randomized Phase 2 Study of 5-Aminolevulinic Acid Hydrochloride and Sodium Ferrous Citrate for the Prevention of Nephrotoxicity Induced by Cisplatin-Based Chemotherapy of Lung Cancer

10. The Incidence of Hemorrhagic Complications Was Lower With the Guide Sheath Than With the Conventional Forceps Biopsy Method

11. Novel ALK-specific mRNA in situ hybridization assay for non-small-cell lung carcinoma

12. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for clinical microbiology in 2014: General view of the pathogens' antibacterial susceptibility

13. Cyclin-dependent kinase 4 upregulation mediates acquired resistance of dabrafenib plus trametinib in

14. The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancer

15. SETD2 and miR-21 as therapeutic targets for NUT midline carcinoma

16. Novel

17. Clinical trial of photodynamic therapy for peripheral-type lung cancers using a new laser device in a pilot study

18. Retraction: Photodynamic Diagnosis for Pleural Disseminated Lesions of Lung Cancer Using a Combination of 5-Aminolevulinic Acid and Autofluorescence Observation System

19. Photodynamic diagnosis of visceral pleural invasion of lung cancer with a combination of 5-aminolevulinic acid and autofluorescence observation systems

20. Activation of Src signaling mediates acquired resistance to ALK inhibition in lung cancer

21. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2012: General view of the pathogens' antibacterial susceptibility

22. Surgical Treatment of Idiopathic Multiple Pulmonary Arteriovenous Malformation Identified at the Onset of Cerebral Infarction: A Case Report

23. The Lymphatic Map of the Lung -Subdivision of N2 Non-small Cell Lung Carcinomas

24. PD-1 Blockers: Staying Long in the Body and Delayed Toxicity Risks

25. A 47-Year-Old Woman With Pulmonary Nodules and Facial Hemispasms

26. Monomerization of ALK Fusion Proteins as a Therapeutic Strategy in

27. Fluorodynamic diagnosis of thoracic malignancies

28. Evaluation of a Quantitative Serological Assay for Diagnosing Chronic Pulmonary Aspergillosis

29. Adverse Drug Reaction Following Quadrivalent Influenza Vaccination Coverage of Health Care Workers

30. Current status of diagnostic and therapeutic bronchoscopy in Japan: 2016 national survey of bronchoscopy

31. Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases

32. Open-label, randomized, comparative, phase III study on effects of reducing steroid use in combination with Palonosetron

33. Histamine <scp> H 1 </scp> antagonist levocetirizine as a potential cause of lung injury

34. Minimal change nephrotic syndrome associated with gefitinib and a successful switch to erlotinib

35. [Persistent Chemotherapy-Induced Hiccups Successfully Treated with Pregabalin]

37. The Diagnosis and Treatment of Lung Cancer

38. Photodynamic Diagnoses of Malignant Pleural Diseases Using the Autofluorescence Imaging System

39. Abstract 2982: Monomerization of ALK fusion proteins as a therapeutic strategy in ALK rearranged cancers

40. Long-term follow-up of pharmacokinetics (PK) and immunogenicity of the anti–PD-1 antibodies nivolumab (Nivo) and pembrolizumab (Pembro) in real-world practice

42. Corrigendum to 'Nationwide surveillance of bacterial respiratory pathogens conducted by the Surveillance Committee of Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Clinical Microbiology in 2009: General view of the pathogens' antibacterial susceptibility' [J Infect Chemother 18 (2012) 609–620]

43. Bronchoscopic practice in Japan: A survey by the Japan Society for Respiratory Endoscopy in 2010

44. Primary Mediastinal Amyloidosis Diagnosed by Transbronchial Needle Aspiration

45. Feasibility of adjuvant chemotherapy with S-1 consisting of a 4-week administration and a two-week rest period in patients with completely resected non-small cell lung cancer

46. Deaths and complications associated with respiratory endoscopy: A survey by the Japan Society for Respiratory Endoscopy in 2010

47. Nicotinamide Phosphoribosyltransferase: A Potent Therapeutic Target in Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor-Gene Mutation

48. EGFR and KRAS Mutations in Triple-Mutated Lung Cancer

49. Phase II Study of Irinotecan plus S-1 Combination for Previously Untreated Advanced Non-Small Cell Lung Cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0601

50. Prevalence, genetic features, and anti-cancer drug sensitivity of NUT midline carcinoma

Catalog

Books, media, physical & digital resources